At Demo SA, one of the world’s largest pharmaceutical manufacturers in injectable facilities, we are currently looking for a high-performing Financial Analyst to join our team. The position is based at Kryoneri (Athens).
Responsibilities
- Support the implementation and monitoring of Budget and Business Plan of the company
- Assist in financial performance analysis and develop forecast models.
- Able to comprehend complex business situations and convert them in financial models.
- Run ad-hoc reporting and support special projects.
- Handle data analysis and verification checks.
- Ensure financial documentation is full and complete.
- Operate as business partner.
- Bachelor’s degree in Finance, Economics, Accounting, Business Administration or other related discipline.
- Master's Degree, CFA, CIMA, or equivalent certification will be considered an asset.
- At least 4 years work experience of which 2 in a similar role.
- MS Office –power user of Excel.
- Working experience with IFRS will be considered as a plus.
- Knowledge of ERP – SAP is a must.
- Experience with data warehouses is highly appreciated.
- Fluency in English.
- Analytical with problem solving skills.
- Proactive, detail oriented, multi-tasking.
- Self-motivated.
The company offers competitive remuneration, continuous learning and development opportunities, and a friendly and challenging working environment.
Top Skills
What We Do
DEMO is a dynamic Greek industrial and commercial organization, specializing in the development, production and supply of pharmaceutical products.
The company is the largest supplier of injectables for public hospitals in Greece, exports 80% of its annual production and is recognized as one of the official suppliers of the United Nations, UNICEF, the World Health Organization (WHO), Doctors Without Borders and the International Committee of the Red Cross. With over 3,300 circulation licenses in 86 countries worldwide, the largest factory in SE Europe and over 1,400 employees, DEMO paves the way for pharmaceutical self-sufficiency for Greece and Europe.
Today, DEMO implements investments of €356 million, strengthening production and R&D, while entering the development and production of active ingredients and Biotechnology.
At the same time, the company is committed to ensuring equality, diversity and inclusion in the working environment and has adopted -within this context- the Diversity Charter for Greece.
DEMO moves "Always Forward" driven by its corporate philosophy of providing quality and reliable pharmaceutical products, for everyone.
Learn more at www.demo.gr
